Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
BioCon
BioCon
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Life science software company EIDA joins forces with blue-chip construction expert Kyron
EIDA Solutions and Kyron Innovative Technologies have formed a strategic partnership following a twelve-year close working relationship
Integrity testing of HEPA filters: A practical approach
Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit...
Legionella testing: Modern alternatives to the ‘gold standard’ test
The development of significantly faster, more sensitive testing protocols provide more options for detection Legionella than the complex plate culture test, but these also have...
A guide to risk assessments for cleanroom containment
Risk assessment is a crucial component of any manufacturing process. Gabriela Mikhaiel from Dec Group discusses the key ways it ensures the well-being of workers and the...
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Sustainability
Biocon Academy see 185 graduates across pharma programmes
The pharmaceutical firm's academy has seen student graduate in programmes on applied microbiology, global regulatory affairs, and quality control
Regulatory
Biocon insulin facility in Malaysia completes FDA PAI Inspection
Despite some observations, Biocon Biologics is confident that it will not affect commercialisation plans
Biocon appoints new CEO
Siddharth Mittal has taken over from Dr Arun Chandavarkar as CEO & Joint Managing Director of India-based Biocon
Regulatory
Biocon biologics facility gets FDA nod
India's biopharmaceutical giant has been investing in expanding manufacturing capacity in line with expectations of higher biosimilars penetration in developed and emerging market
Subscribe now